Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature
Background Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor’s capacity for relapse and to develop distant metastases. These tumors can present the same evol...
Gespeichert in:
| Veröffentlicht in: | World journal of surgical oncology Jg. 17; H. 1; S. 70 - 8 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
London
BioMed Central
16.04.2019
BioMed Central Ltd BMC |
| Schlagworte: | |
| ISSN: | 1477-7819, 1477-7819 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | Background
Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor’s capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma.
Case description
We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases.
Conclusions
To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. |
|---|---|
| AbstractList | Background
Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor’s capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma.
Case description
We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases.
Conclusions
To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. Background Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor's capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma. Case description We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases. Conclusions To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. Keywords: Bevacizumab, Brain metastases, Gastro-intestinal tract metastases, Malignant meningioma, Systemic treatment Background Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor’s capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma. Case description We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases. Conclusions To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor's capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma.BACKGROUNDMeningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor's capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma.We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases.CASE DESCRIPTIONWe report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases.To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma.CONCLUSIONSTo our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor's capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma. To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. Abstract Background Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor’s capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma. Case description We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases. Conclusions To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor's capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma. We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases. To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma. |
| ArticleNumber | 70 |
| Audience | Academic |
| Author | Helali, Mehdi Lhermitte, Benoit Bender, Laura Carinato, Hélène Baloglu, Seyyid Cebula, Hélène Antoni, Delphine Noel, Georges |
| Author_xml | – sequence: 1 givenname: Laura orcidid: 0000-0003-3486-8505 surname: Bender fullname: Bender, Laura email: laura_2708@hotmail.fr organization: Radiotherapy Department, Centre Paul Strauss, UNICANCER – sequence: 2 givenname: Benoit surname: Lhermitte fullname: Lhermitte, Benoit organization: Pathology Service, University Hospital Hautepierre – sequence: 3 givenname: Hélène surname: Carinato fullname: Carinato, Hélène organization: Medical Oncology Department, Centre Paul Strauss, UNICANCER – sequence: 4 givenname: Seyyid surname: Baloglu fullname: Baloglu, Seyyid organization: Radiology Department, University Hospital Hautepierre – sequence: 5 givenname: Mehdi surname: Helali fullname: Helali, Mehdi organization: Nuclear Medecine Department, Centre Paul Strauss, UNICANCER – sequence: 6 givenname: Hélène surname: Cebula fullname: Cebula, Hélène organization: Neurosurgery Department, University Hospital Hautepierre – sequence: 7 givenname: Delphine surname: Antoni fullname: Antoni, Delphine organization: Radiotherapy Department, Centre Paul Strauss, UNICANCER, CNRS, IPHC UMR 7178, Centre Paul Strauss, UNICANCER, Université de Strasbourg – sequence: 8 givenname: Georges surname: Noel fullname: Noel, Georges organization: Radiotherapy Department, Centre Paul Strauss, UNICANCER, CNRS, IPHC UMR 7178, Centre Paul Strauss, UNICANCER, Université de Strasbourg |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30992070$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9kktv1DAUhSNURB_wA9igSEiITYofiWOzQKoqKCNVYgNry7FvMh5l7MF2WvHvcZrSzlSAvLDlfOfc5OScFkfOOyiK1xidY8zZh4iJaNoKYVHhRrCKPStOcN22VcuxONo7HxenMW4QIpQ29EVxTJEQBLXopNhdBWWgXK1W5RacdYP1W1Xe2rQuBxVT8JV1CWKyTo1lCkqnUjlTdkFZlxUpMypC_FjqvJUBdj4sRIAbC7el78u0hnK0CYJKU4CXxfNejRFe3e9nxY8vn79ffq2uv12tLi-uK81onSpOBRgBjPctbzDvKNPKIMAYG9w2SgPqOsQI7jHhBrGOcCKgN8LQWtG-a-lZsVp8jVcbuQt2q8Iv6ZWVdxc-DFKFZPUIUpOWcKowpYjVmHRd1wsOzBDW1NDi2evT4rWbui0YDS4nMR6YHj5xdi0HfyNZzQRGLBu8vzcI_ueU45RbGzWMo3LgpygJwUgw0tQio2-foBs_hZz-HYWbumWcP1KDyh9gXe_nfzObyouGU8wpq-tMnf-FysvA1urcpd7m-wPBuz3BGtSY1tGPU7LexUPwzX4iD1H8KVYG8ALo4GMM0D8gGMm5vHIpr8zllXN55ZxS-0SjbVLz7PzadvyvkizKmKe4AcJjaP8W_QZYGQEQ |
| CitedBy_id | crossref_primary_10_1177_19714009221096836 crossref_primary_10_1016_j_ijso_2021_100327 crossref_primary_10_3389_fonc_2020_558845 crossref_primary_10_3390_diagnostics15050538 |
| Cites_doi | 10.3389/fsurg.2016.00040 10.1016/S0303-8467(00)00119-0 10.1007/BF01809747 10.1002/cncr.20109 10.1016/S0090-3019(02)00917-5 10.1093/neuonc/nou148 10.1016/S1470-2045(16)30321-7 10.1007/s11060-014-1358-9 10.1007/s11060-010-0381-8 10.1227/00006123-198910000-00003 10.1007/s00280-015-2927-0 10.1007/s11060-013-1074-x 10.1093/neuonc/nov183 10.1093/neuonc/nov069 10.1007/s11060-010-0342-2 10.1097/00005072-198701000-00005 10.1093/neuonc/nos218 10.4149/neo_2013_062 10.1007/s00280-014-2422-z 10.1016/j.ijrobp.2008.10.053 10.1111/j.1440-1827.2008.02335.x 10.3171/jns.1993.78.3.0456 10.1016/j.humpath.2004.07.017 10.1007/s11060-010-0386-3 10.1007/s11060-012-0861-0 |
| ContentType | Journal Article |
| Copyright | The Author(s). 2019 COPYRIGHT 2019 BioMed Central Ltd. 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| Copyright_xml | – notice: The Author(s). 2019 – notice: COPYRIGHT 2019 BioMed Central Ltd. – notice: 2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. |
| DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7QO 7X7 7XB 88E 8FD 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR C1K CCPQU DWQXO FR3 FYUFA GHDGH K9. M0S M1P P64 PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM DOA |
| DOI | 10.1186/s12957-019-1596-6 |
| DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic ProQuest Publicly Available Content ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China Environmental Sciences and Pollution Management ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | Publicly Available Content Database MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1477-7819 |
| EndPage | 8 |
| ExternalDocumentID | oai_doaj_org_article_c27283a13306412bbbf98e6d2654e717 PMC6469106 A583183644 30992070 10_1186_s12957_019_1596_6 |
| Genre | Journal Article Review Case Reports |
| GeographicLocations | France United States--US |
| GeographicLocations_xml | – name: France – name: United States--US |
| GroupedDBID | --- 0R~ 29R 2WC 53G 5VS 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML ABDBF ABUWG ACGFO ACGFS ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EBD EBLON EBS EJD ESX F5P FYUFA GROUPED_DOAJ GX1 HMCUK HYE IAO IHR IHW INH INR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SMD SOJ TR2 TUS UKHRP W2D WOQ WOW XSB ~8M AAYXX AFFHD CITATION ALIPV CGR CUY CVF ECM EIF NPM 3V. 7QL 7QO 7XB 8FD 8FK AZQEC C1K DWQXO FR3 K9. P64 PKEHL PQEST PQUKI PRINS 7X8 5PM |
| ID | FETCH-LOGICAL-c634t-839ed9e68f78518b36cad0e111d175ace0bb0621f128d06b2829efd9d34a3fb73 |
| IEDL.DBID | BENPR |
| ISICitedReferencesCount | 6 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000464903300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1477-7819 |
| IngestDate | Fri Oct 03 12:53:16 EDT 2025 Tue Nov 04 01:57:56 EST 2025 Fri Sep 05 06:28:07 EDT 2025 Mon Oct 06 18:24:10 EDT 2025 Tue Nov 11 10:28:56 EST 2025 Tue Nov 04 18:06:40 EST 2025 Thu May 22 21:22:20 EDT 2025 Thu Apr 03 06:59:21 EDT 2025 Sat Nov 29 03:38:53 EST 2025 Tue Nov 18 21:01:47 EST 2025 Sat Sep 06 07:30:28 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Systemic treatment Brain metastases Malignant meningioma Gastro-intestinal tract metastases Bevacizumab |
| Language | English |
| License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c634t-839ed9e68f78518b36cad0e111d175ace0bb0621f128d06b2829efd9d34a3fb73 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Case Study-2 ObjectType-Review-5 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3 |
| ORCID | 0000-0003-3486-8505 |
| OpenAccessLink | https://www.proquest.com/docview/2211547688?pq-origsite=%requestingapplication% |
| PMID | 30992070 |
| PQID | 2211547688 |
| PQPubID | 42870 |
| PageCount | 8 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_c27283a13306412bbbf98e6d2654e717 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6469106 proquest_miscellaneous_2210962549 proquest_journals_2211547688 gale_infotracmisc_A583183644 gale_infotracacademiconefile_A583183644 gale_healthsolutions_A583183644 pubmed_primary_30992070 crossref_primary_10_1186_s12957_019_1596_6 crossref_citationtrail_10_1186_s12957_019_1596_6 springer_journals_10_1186_s12957_019_1596_6 |
| PublicationCentury | 2000 |
| PublicationDate | 2019-04-16 |
| PublicationDateYYYYMMDD | 2019-04-16 |
| PublicationDate_xml | – month: 04 year: 2019 text: 2019-04-16 day: 16 |
| PublicationDecade | 2010 |
| PublicationPlace | London |
| PublicationPlace_xml | – name: London – name: England |
| PublicationTitle | World journal of surgical oncology |
| PublicationTitleAbbrev | World J Surg Onc |
| PublicationTitleAlternate | World J Surg Oncol |
| PublicationYear | 2019 |
| Publisher | BioMed Central BioMed Central Ltd BMC |
| Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd – name: BMC |
| References | M Maxwell (1596_CR5) 1993; 78 J Furtner (1596_CR22) 2016; 18 J Wiemels (1596_CR2) 2010; 99 1596_CR8 1596_CR7 SA Enam (1596_CR10) 1996; 138 M Simó (1596_CR20) 2014; 73 Y Takahashi (1596_CR17) 2009; 59 A Surov (1596_CR11) 2013; 112 E Mazza (1596_CR25) 2016; 77 S Soyuer (1596_CR14) 2004; 100 1596_CR24 JJ Raizer (1596_CR23) 2014; 117 T Backer-Grøndahl (1596_CR9) 2012; 5 BT Ragel (1596_CR6) 2010; 99 TA Dolecek (1596_CR1) 2012; 14 VR Kshettry (1596_CR3) 2015; 17 JH Kim (1596_CR15) 2003; 59 1596_CR18 1596_CR19 BL Guthrie (1596_CR16) 1989; 25 1596_CR13 J Holden (1596_CR4) 1987; 46 C Mawrin (1596_CR12) 2010; 99 E Lou (1596_CR21) 2012; 109 TJ Kaley (1596_CR26) 2015; 17 |
| References_xml | – ident: 1596_CR8 doi: 10.3389/fsurg.2016.00040 – ident: 1596_CR24 doi: 10.1016/S0303-8467(00)00119-0 – volume: 138 start-page: 1172 issue: 10 year: 1996 ident: 1596_CR10 publication-title: Acta Neurochir doi: 10.1007/BF01809747 – volume: 100 start-page: 1491 issue: 7 year: 2004 ident: 1596_CR14 publication-title: Cancer doi: 10.1002/cncr.20109 – volume: 59 start-page: 47 issue: 1 year: 2003 ident: 1596_CR15 publication-title: Surg Neurol doi: 10.1016/S0090-3019(02)00917-5 – volume: 17 start-page: 116 issue: 1 year: 2015 ident: 1596_CR26 publication-title: Neuro Oncol doi: 10.1093/neuonc/nou148 – ident: 1596_CR18 doi: 10.1016/S1470-2045(16)30321-7 – volume: 117 start-page: 93 issue: 1 year: 2014 ident: 1596_CR23 publication-title: J Neuro-Oncol doi: 10.1007/s11060-014-1358-9 – volume: 99 start-page: 315 issue: 3 year: 2010 ident: 1596_CR6 publication-title: J Neuro-Oncol doi: 10.1007/s11060-010-0381-8 – volume: 25 start-page: 514 issue: 4 year: 1989 ident: 1596_CR16 publication-title: Neurosurgery doi: 10.1227/00006123-198910000-00003 – volume: 77 start-page: 115 issue: 1 year: 2016 ident: 1596_CR25 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-015-2927-0 – volume: 112 start-page: 323 issue: 3 year: 2013 ident: 1596_CR11 publication-title: J Neuro-Oncol doi: 10.1007/s11060-013-1074-x – volume: 18 start-page: 401 issue: 3 year: 2016 ident: 1596_CR22 publication-title: Neuro Oncol doi: 10.1093/neuonc/nov183 – volume: 17 start-page: 1166 issue: 8 year: 2015 ident: 1596_CR3 publication-title: Neuro Oncol doi: 10.1093/neuonc/nov069 – volume: 5 start-page: 231 issue: 3 year: 2012 ident: 1596_CR9 publication-title: Int J Clin Exp Pathol – volume: 99 start-page: 379 issue: 3 year: 2010 ident: 1596_CR12 publication-title: J Neuro-Oncol doi: 10.1007/s11060-010-0342-2 – volume: 46 start-page: 50 issue: 1 year: 1987 ident: 1596_CR4 publication-title: J Neuropathol Exp Neurol doi: 10.1097/00005072-198701000-00005 – volume: 14 start-page: v1 issue: suppl 5 year: 2012 ident: 1596_CR1 publication-title: Neuro Oncol doi: 10.1093/neuonc/nos218 – ident: 1596_CR7 doi: 10.4149/neo_2013_062 – volume: 73 start-page: 919 issue: 5 year: 2014 ident: 1596_CR20 publication-title: Cancer Chemother Pharmacol doi: 10.1007/s00280-014-2422-z – ident: 1596_CR19 doi: 10.1016/j.ijrobp.2008.10.053 – volume: 59 start-page: 98 issue: 2 year: 2009 ident: 1596_CR17 publication-title: Pathol Int doi: 10.1111/j.1440-1827.2008.02335.x – volume: 78 start-page: 456 issue: 3 year: 1993 ident: 1596_CR5 publication-title: J Neurosurg doi: 10.3171/jns.1993.78.3.0456 – ident: 1596_CR13 doi: 10.1016/j.humpath.2004.07.017 – volume: 99 start-page: 307 issue: 3 year: 2010 ident: 1596_CR2 publication-title: J Neuro-Oncol doi: 10.1007/s11060-010-0386-3 – volume: 109 start-page: 63 issue: 1 year: 2012 ident: 1596_CR21 publication-title: J Neuro-Oncol doi: 10.1007/s11060-012-0861-0 |
| SSID | ssj0023353 |
| Score | 2.205953 |
| SecondaryResourceType | review_article |
| Snippet | Background
Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients... Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these... Background Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients... Abstract Background Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the... |
| SourceID | doaj pubmedcentral proquest gale pubmed crossref springer |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 70 |
| SubjectTerms | Aged Angiogenesis inhibitors Antibodies Antigens Bevacizumab Brain Brain cancer Brain metastases Brain Neoplasms - secondary Brain Neoplasms - therapy Brain tumors Cancer Cancer metastasis Cancer therapies Carcinoma Care and treatment Case Report Case reports Case studies Causes of Classification Diagnosis Edema Endothelial growth factors Family medical history Gastro-intestinal tract metastases Gastrointestinal cancer Gastrointestinal Neoplasms - secondary Gastrointestinal Neoplasms - therapy Gastrointestinal system Guidelines Humans Hypotheses Immunotherapy Intestine Kinases Literature reviews Male Malignant meningioma Medical prognosis Medicine Medicine & Public Health Melanoma Meningeal Neoplasms - pathology Meningeal Neoplasms - therapy Meningioma Meningioma - pathology Meningioma - therapy Metastases Metastasis Monoclonal antibodies Mutation Neoplasm Grading Nervous system NMR Nuclear magnetic resonance Patient outcomes Patients Phenols (Class of compounds) Platelet-derived growth factor Protein-tyrosine kinase Radiation therapy Radiotherapy Recurrence (Disease) Somatostatin Surgery Surgical Oncology Systemic treatment Targeted cancer therapy Tumors Tyrosine Vascular endothelial growth factor Vascular endothelial growth factor receptors |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9UwFA8yRHwRv61OjSAISlibtPnwbYrTCzp8UNlbSJp0DrZ23Hb7-3dO2lvXifri04Wbk9J7PvI7557kF0JeGiU0DBkGtg2sNEVk2nnBEG0EnkjgiXj-x2e1v68PDszXS1d94Z6wkR54VNxOzRUgoINSCsCz4N77xugoA5dVGaEWwdU3V2ZTTE2llhCVmHqYhZY7PaBahVssDQP4lkwuUCiR9f--JF_CpKv7Ja80TRMW7d0mt6Ykku6OL3-HXIvtXXLjy9Qmv0dOP65diHS1WtGTmK4k6k4cxb9c6aHrh3XHkCUCghufMuA5KeraQD1eFwEzBpABcOvf0ho-6NhWSBLjQRfaNRTyRno8UzLfJ9_3Pnx7_4lNVyuwWopyYJAWxWCi1I2ClEt7IWsX8ggLX4B8wtUx9z6XvGgAvkIuPfZbYxNMEKUTjVfiAdlquzY-IrQBjNemNoVXsmy4cJgh8dIHVcGjeJWRfKNqW0-843j9xbFN9YeWdrSOBetYtI6VGXk9TzkdSTf-JvwO7TcLIl92-gK8yE5eZP_lRRl5jta34-HTOertbqVx0YOkMSOvkgTGPRrGTccXQAnIoLWQ3F5IQrzWy-GNh9lpvegt50iLBKWfzsiLeRhn4h64NnZnSQbqTSzoM_JwdMj5RwtI9CEM8oyohasutLIcaY9-JjZxWUpIGUGNbzZO_eu1_qj0x_9D6U_ITY4hicyZcptsDeuz-JRcr8-Ho379LAX0Bbk7Sfg priority: 102 providerName: Directory of Open Access Journals – databaseName: SpringerLink dbid: RSV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bi9UwEA66iuyLd93qqhEEQQn2JG2a-LaKqwd0EdRl30LSpOvCbru0XX-_M-lFu15Anw6cTA6nk8nMN53MF0Ke6EIoGNIM1tazTK8CU9YJhtFGYEcCj8Tz---LvT11cKA_jn3c3XTafSpJRk8dt7WSLzqITDkek9QMQrBk8iK5lCPZDKbon_bnLEuIXIzly99OWwSgyNP_qzf-KRydPyp5rl4aw9Dutf96gOvk6og66c5gJjfIhVDfJFc-jHX1W-T0bWt9oOv1mp6EeIdRc2IpvqOlh7br24YhrQR4A_yVHhurqK09dXi_BMzoQQaiYfeSlvBBhzpElBg6Y2hTUQCa9HjmcL5Nvuy--fz6HRvvYmClFFnPAEcFr4NUVQEYTTkhS-vTAJ7SAwCxZUidSyVfVRDvfCodFmhD5bUXmRWVK8QdslE3ddgitAJQoHSpV66QWcWFRUjFM-eLHH6K5wlJpwUy5UhUjvdlHJuYsChpBk0a0KRBTRqZkGfzlNOBpeNvwq9w1WdBJNiOXzTtoRn3qyl5AcDLQgYPmG3FnXOVVkF6LvMsQAqckEdoM2boVp3dhNnJFXpJQJkJeRol0FHgwtix3wGUgJRbC8nthSRs8HI5PNmlGR1MZzhHHiXIFVVCHs_DOBMPzdWhOYsykKDiG4CE3B3MeH5oAZkBB3efkGJh4AutLEfqo6-RflxmEjAmqPH5ZOY__tYflX7vn6Tvk02O-wQ5NeU22ejbs_CAXC6_9Udd-zDu9--rH07L priority: 102 providerName: Springer Nature |
| Title | Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature |
| URI | https://link.springer.com/article/10.1186/s12957-019-1596-6 https://www.ncbi.nlm.nih.gov/pubmed/30992070 https://www.proquest.com/docview/2211547688 https://www.proquest.com/docview/2210962549 https://pubmed.ncbi.nlm.nih.gov/PMC6469106 https://doaj.org/article/c27283a13306412bbbf98e6d2654e717 |
| Volume | 17 |
| WOSCitedRecordID | wos000464903300002&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1477-7819 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023353 issn: 1477-7819 databaseCode: RBZ dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1477-7819 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023353 issn: 1477-7819 databaseCode: DOA dateStart: 20030101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1477-7819 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023353 issn: 1477-7819 databaseCode: M~E dateStart: 20030101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1477-7819 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023353 issn: 1477-7819 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1477-7819 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023353 issn: 1477-7819 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1477-7819 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023353 issn: 1477-7819 databaseCode: PIMPY dateStart: 20090101 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVAVX databaseName: SpringerLink customDbUrl: eissn: 1477-7819 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0023353 issn: 1477-7819 databaseCode: RSV dateStart: 20031201 isFulltext: true titleUrlDefault: https://link.springer.com/search?facet-content-type=%22Journal%22 providerName: Springer Nature |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYhhAvfH8ERjESEhIoWmsnjsML2tAGlVhVDZi2J8uOnTFpS0qT8fdz57gZGWIvvLRKfY5q3_k-fPbvCHmdZ1xCUx4Db22c5BMXS214jNaG440E5oHnD79ks5k8OsrnYcOtCccqVzrRK2pbF7hHvsUYAseAcyw_LH7GWDUKs6uhhMYa2UCkMpDzjZ3d2fygD7k4T3nIZU6k2GrAuqV41DKPwYyLWAyskQft_1s1_2Gbrp6bvJI89TZp7-7_juYeuRO8Ubrdic99csNVD8it_ZBvf0gWn5baOjqdTum587WN6nNNce-WnuimXdYxwk2AlsC3tHjhiurKUoN1J6BHCzRgJZv3tIAv2uUnPEV3Y4bWJQUHlJ712M6PyPe93W8fP8ehRkNcCJ60MfhXzuZOyDID300aLgptxw40qAXHRBdubMxYsEkJdtCOhcHErSttbnmieWky_pisV3XlnhJagrMg8yKfmEwkJeMaXS2WGJul8CqWRmS84pUqAoA51tE4Uz6QkUJ17FXAXoXsVSIib_suiw694zriHRSAnhCBt_0P9fJEhXWsCpaBQ6YhsgdfbsKMMWUunbBMpImD0DgiL1F8VHeLtVcfajuVqD3B-4zIG0-BCgQZo8M9CJgEhOIaUG4OKGHhF8PmlWypoHgadSlYEXnVN2NPPExXufrC00DgijsDEXnSSXQ_aA4RAwMzEJFsIOuDWRm2VKc_PCy5SAT4njCN71ar4vJv_XPSn10_iOfkNsPViuCaYpOst8sL94LcLH61p81yRNayo8x_ylFY-SO_qQJP8-n-_BieDr4e_gZpB1_9 |
| linkProvider | ProQuest |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB6VLQIuvB-BQo0EQgJF3diJkyAh1EJLV21XFSqoNxPHTqnUJssmBfGn-I3M5FVSRG89cFopHltrex7f2J4ZgGdxKCJsil3cW-P6sWfdKNHCJWsjKCKB14nnP2-H02m0vx_vLsCvLhaGnlV2OrFW1KZI6Yx8hXNKHIPgOHo7--ZS1Si6Xe1KaDRssWV__kCXrXwzeY_7-5zzjfW9d5tuW1XATaXwKxcRgTWxlVFGdekjLWSamLFFmTdoSpPUjrUeS-5lqLnNWGq6arSZiY3wE5HpUOC4l2DRF74MRrC4tj7d_di7eEIEor079SK5UqI1DehpZ-wibJCuHFi_ukjA36bgD1t49p3mmcva2gZu3PjfVu8mXG_RNlttxOMWLNj8NlzZad8T3IHZh3liLJtMJuzY1rWbiuOE0dk0O0jKal64lE4DtSCNUlFAGUtywzTV1cAeFdIgCihfsxR_WHP_UlM0EUGsyBgCbHbU566-C58uZL73YJQXuX0ALEMwFMVp7OlQ-hkXCUFJ7msTBjgUDxwYd7yh0jZBO9UJOVK1oxZJ1bCTQnZSxE5KOvCy7zJrspOcR7xGDNcTUmLx-kMxP1CtnlIpDxFwJp4gz9TjWussjqw0XAa-RdffgWViV9VE6fbqUa0GEVkHRNcOvKgpSEHSxiRtnAcuAqUaG1AuDShRsaXD5o6XVatYS3XKyA487ZupJz0WzG1xUtOgY04nHw7cbySon7RAj4ijmXMgHMjWYFWGLfnh1zrtuvQlYmtcxledFJ7-rX8u-sPzJ7EMVzf3drbV9mS69QiucdIUlEhULsGomp_Yx3A5_V4dlvMnraZh8OWixfM3hce3oA |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Zb9QwEB5BQRUv3EegUCMhIYGi7tqJ4_BWjoUVZVVxVH2z7NgpldpktUn5_cw42UDKISGeVorH0WYynvkm4_kM8CTPhMKhPMZ36-Ikn_pYGStiijaCOhJ4IJ4_2MsWC3V4mO_355w2693u65Jk19NALE1Vu7N0ZbfEldxpMEqltGUyjzEcy1hehEsJJjK0p-vjp4Mh4xIiFX0p87fTRsEocPb_6pl_Ck3nt02eq52GkDS79t8Pcx2u9miU7XbmcwMu-OombH7o6-23YPl2ZZxn8_mcnfpwtlF9ahh9u2VHpmlXdUx0E-gl6C4tNVwxUzlm6dwJnNGiDEbJ5gUr8Id19Ykg0XXMsLpkCEDZycDtfBu-zN58fvUu7s9oiAspkjZGfOVd7qUqM8RuygpZGDfx6EEdAhNT-Im1E8mnJcZBN5GWCre-dLkTiRGlzcQd2Kjqyt8DViJYUHmRT20mk5ILQ1CLJ9ZlKd6KpxFM1i9LFz2BOZ2jcaJDIqOk7jSpUZOaNKllBM-GKcuOveNvwi_JAgZBIt4OF-rVke7XsS54hoDMYGaPWG7KrbVlrrx0XKaJx9Q4gm2yH911sQ7uQ--mirwnos8IngYJciD0YkzfB4FKICqukeTWSBIXfjEeXtuo7h1PozknfiXMIVUEj4dhmkmb6SpfnwUZTFzpy0AEdzuTHh5aYMbAMQxEkI2MfaSV8Uh1_DXQkstEIvZENT5fm_yPv_VHpd__J-lt2Nx_PdN788X7B3CF05Ih2k25BRvt6sw_hMvFt_a4WT0KbuA7hj1akw |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Grade+III+meningioma+with+gastro-intestinal+tract+and+brain+metastases%3A+case+report+and+review+of+the+literature&rft.jtitle=World+journal+of+surgical+oncology&rft.au=Bender%2C+Laura&rft.au=Lhermitte%2C+Benoit&rft.au=Carinato%2C+H%C3%A9l%C3%A8ne&rft.au=Baloglu%2C+Seyyid&rft.date=2019-04-16&rft.issn=1477-7819&rft.eissn=1477-7819&rft.volume=17&rft.issue=1&rft.spage=70&rft_id=info:doi/10.1186%2Fs12957-019-1596-6&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1477-7819&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1477-7819&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1477-7819&client=summon |